HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center

HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center

Abstract Background Hemophagocytic lymphohistiocytosis (HLH) is a severe or even fatal inflammatory state. Epstein–Barr virus (EBV) infection-associated HLH (EBV-HLH) is one of the most common secondary HLH and suffers a very poor prognosis. Allo-HSCT is often required for refractory EBV-HLH, but so...

Full description

Bibliographic Details
Main Authors: Yue Song, Jingshi Wang, Yini Wang, Zhao Wang
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Stem Cell Research & Therapy
Subjects:
Hemophagocytic lymphohistiocytosis
Epstein-Barr virus
GPBSC infusion
Salvage therapy
Online Access:http://link.springer.com/article/10.1186/s13287-020-01779-4

Internet

http://link.springer.com/article/10.1186/s13287-020-01779-4

Similar Items